Key points are not available for this paper at this time.
Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, we hypothesized that people with elevated high-sensitivity C-reactive protein levels but without hyperlipidemia might benefit from statin treatment.
Building similarity graph...
Analyzing shared references across papers
Loading...
Paul M. Ridker
Eleanor Danielson
Francisco Antônio Helfenstein Fonseca
New England Journal of Medicine
Harvard University
Brigham and Women's Hospital
University of Amsterdam
Building similarity graph...
Analyzing shared references across papers
Loading...
Ridker et al. (Sun,) studied this question.
www.synapsesocial.com/papers/6902267182e6c353f8456ca9 — DOI: https://doi.org/10.1056/nejmoa0807646